Development of Staging Guidelines for Metastatic Breast Cancer: Which method is best?
Conferences
Plichta, JK; Rey, V; Blasingame, M; Luo, S; Thomas, SM
Published in: CLINICAL CANCER RESEARCH
February 17, 2026
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
CLINICAL CANCER RESEARCH
EISSN
1557-3265
ISSN
1078-0432
Publication Date
February 17, 2026
Volume
32
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Plichta, J. K., Rey, V., Blasingame, M., Luo, S., & Thomas, S. M. (2026). Development of Staging Guidelines for Metastatic Breast Cancer: Which method is best? In CLINICAL CANCER RESEARCH (Vol. 32).
Plichta, J. K., V. Rey, M. Blasingame, S. Luo, and S. M. Thomas. “Development of Staging Guidelines for Metastatic Breast Cancer: Which method is best?” In CLINICAL CANCER RESEARCH, Vol. 32, 2026.
Plichta JK, Rey V, Blasingame M, Luo S, Thomas SM. Development of Staging Guidelines for Metastatic Breast Cancer: Which method is best? In: CLINICAL CANCER RESEARCH. 2026.
Plichta, J. K., et al. “Development of Staging Guidelines for Metastatic Breast Cancer: Which method is best?” CLINICAL CANCER RESEARCH, vol. 32, 2026.
Plichta JK, Rey V, Blasingame M, Luo S, Thomas SM. Development of Staging Guidelines for Metastatic Breast Cancer: Which method is best? CLINICAL CANCER RESEARCH. 2026.
Published In
CLINICAL CANCER RESEARCH
EISSN
1557-3265
ISSN
1078-0432
Publication Date
February 17, 2026
Volume
32
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences